Prosecution Insights
Last updated: April 19, 2026
Application No. 18/261,182

PROCESS FOR PRODUCTION OF INTERMEDIATES

Final Rejection §103
Filed
Jul 12, 2023
Examiner
HAVLIN, ROBERT H
Art Unit
1626
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
DSM IP ASSETS B.V.
OA Round
2 (Final)
53%
Grant Probability
Moderate
3-4
OA Rounds
2y 11m
To Grant
80%
With Interview

Examiner Intelligence

Grants 53% of resolved cases
53%
Career Allow Rate
534 granted / 1016 resolved
-7.4% vs TC avg
Strong +27% interview lift
Without
With
+27.2%
Interview Lift
resolved cases with interview
Typical timeline
2y 11m
Avg Prosecution
99 currently pending
Career history
1115
Total Applications
across all art units

Statute-Specific Performance

§101
1.0%
-39.0% vs TC avg
§103
30.8%
-9.2% vs TC avg
§102
24.8%
-15.2% vs TC avg
§112
28.2%
-11.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1016 resolved cases

Office Action

§103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Priority This application is a 371 of PCT/EP2022/050708 (01/14/2022) and claims foreign priority to EP 21154605.6 (02/01/2021). Status Claims 1-2, 5-12 are pending. Claim rejections not reiterated in this action are withdrawn. New Claim Rejections - 35 USC § 103 Claims 1-2, 5-11 are rejected under 35 U.S.C. 103 as being unpatentable over Kienzel et al. (Machine Translation of: Helv. Chimica Acta., v. 58, 1 (1975), No. 4, p. 27-39) in view of Kotha et al. (Heterocycles, v. 90, no. 1, 2015, p. 226-237), Subramanian et al. (Synth. Comm., 27:23, p. 4067-4072), Subramanian et al (Tetrahedron Letters, Vol. 38, No. 14, pp.2585-2586, 1997) (Subramanian-2) and Turk et al. (“Formation of Five-membered Cyclic Sulfones”, chapter 2 in 1,4-Cycloaddition Reactions, Ed. Hamer, Academic Press, 1967, p. 13-45). Kienzle teaches forming polyene products such as Vitamin A using a scheme such as taught on page 34: PNG media_image1.png 287 787 media_image1.png Greyscale PNG media_image2.png 130 781 media_image2.png Greyscale PNG media_image3.png 118 187 media_image3.png Greyscale PNG media_image4.png 274 987 media_image4.png Greyscale Kienzle’s product, compound 23, corresponds to claim 1’s formula (I) where R is CH3, R1 is PNG media_image5.png 163 201 media_image5.png Greyscale , and Kienzle’s reaction, compound 6, similarly has the same R/R1 meaning as claim 1’s formula (II). Kienzle does not specify an alcohol solvent. Kotha teaches in Scheme 3, page 228, the following reaction: PNG media_image6.png 101 250 media_image6.png Greyscale which corresponds to claim 1’s formula (I) when R is CH3, R1 is H, and reacted with SO2 in methanol at rt (20-25C), and has hydroquinone as stabilizer. Kotha teaches the yield was 83%. Subramanian teaches versatile building blocks for the synthesis of natural products with conjugated diene systems via 3-sulfolenes (p. 4067). Subramanian teaches compound 8 (p. 4069): PNG media_image7.png 290 334 media_image7.png Greyscale which is used in the synthesis of chamigrene. Subramanian-2 teaches the use of sulfolene in the synthesis of retinoids/Vitamin A as shown in Scheme I. Turk teaches the well-known synthetic technique of forming cyclic sulfones with dienes exemplified by the following (p. 13): PNG media_image8.png 93 432 media_image8.png Greyscale including a variety of different dienes as shown in Table 1 where an inhibitor/stabilizer is used, including TBP also known as 4-tert-butylcatechol (p. 18-19). One of ordinary skill in the art following the teaching of Kienzle would have considered the known synthetic techniques such as taught by Kotha which is an analogous reaction, in formulating a synthesis of natural products such as chamigrene and vitamin A as taught by Subramanian and Subramanian-2. One of ordinary skill in the art would have considered utilizing the solvent methanol in the Kienzle process because of Kotha and Turks teaching of success in the related process. One of ordinary skill in the art would be motivated to combine the references because of Kotha’s teaching of high yield of 83%. One of ordinary skill in the art would have had a reasonable expectation of success in the combination to arrive at the claimed invention because of the structural similarities in the products and the well-known technique for using sulfones/sulfolenes as taught by Turk. With each of the claims, the level of skill in the art is very high such that one of ordinary skill in the art would consider routine the combination of elements from the teaching of the art. One of ordinary skill in the art would have recognized that the results of the combination would be predictable due to the well-known nature and optimizations routinely performed in the art. Thus, one of ordinary skill in the art would have arrived at the invention as claimed before the effective filing date with a reasonable expectation of success. Conclusion Claim 12 as amended is allowable over the prior art of record. No other claims allowable. Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to ROBERT H HAVLIN whose telephone number is (571)272-9066. The examiner can normally be reached 9am - 6pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Kortney Klinkel can be reached at (571) 270-5293. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ROBERT H HAVLIN/Primary Patent Examiner, Art Unit 1626
Read full office action

Prosecution Timeline

Jul 12, 2023
Application Filed
Nov 07, 2025
Non-Final Rejection — §103
Feb 12, 2026
Response Filed
Mar 20, 2026
Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12528943
Reactive Disperse Yellow Dye for Supercritical CO2 Dyeing and Methods of Production and Use Thereof
2y 5m to grant Granted Jan 20, 2026
Patent 12516383
METHODS FOR DETECTING HEREDITARY CANCERS
2y 5m to grant Granted Jan 06, 2026
Patent 11993569
3-AMINO-4-HALOCYCLOPENTENE CARBOXYLIC ACIDS AS INACTIVATORS OF AMINOTRANSFERASES
2y 5m to grant Granted May 28, 2024
Patent 11952362
COMPOSITIONS AND METHODS FOR TREATING EPIGENETIC DISEASE
2y 5m to grant Granted Apr 09, 2024
Patent 11926871
SYNTHESIZING BARCODING SEQUENCES UTILIZING PHASE-SHIFT BLOCKS AND USES THEREOF
2y 5m to grant Granted Mar 12, 2024
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
53%
Grant Probability
80%
With Interview (+27.2%)
2y 11m
Median Time to Grant
Moderate
PTA Risk
Based on 1016 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month